spikeup, you were very correct with your statement on the new projected larger premises; "This will give the Co more control over product development and commercial manufacturing".
Before even moving there, they already have or just signed onto being the supplier of 3 different cancer research companies. Once they are set up and the first trial is complete the doors to their shop will begin to move on manufacturing. Imagine the potential for other cancer research facility to do what Patry's Limited is about to do, same as NewPhase and GCT, with these nanaparticles.
A quote from them; " PAT DX1 Collaboration with Imagion which is a cancer imaging diagnostic company. So our deoxymabs will be used to bind to cancer targets which will create new ways to visualise and diagnose cancer through imaging."
IBX Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
